Plants as bioreactors for the production of vaccine antigens

Plants have been identified as promising expression systems for commercial production of vaccine antigens. In phase I clinical trials several plant-derived vaccine antigens have been found to be safe and induce sufficiently high immune response. Thus, transgenic plants, including edible plant parts...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiwari, Siddharth, Verma, Praveen C., Singh, Pradhyumna K., Tuli, Rakesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2009
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126855/
https://www.ncbi.nlm.nih.gov/pubmed/19356740
http://dx.doi.org/10.1016/j.biotechadv.2009.03.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126855/
https://www.ncbi.nlm.nih.gov/pubmed/19356740
http://dx.doi.org/10.1016/j.biotechadv.2009.03.006

Ejemplares similares